EODData

MEMBERSHIP REGISTER LOG IN

FRA, R9Q: RECCE PHARMACEUTICALS LTD

23 Dec 2025
LAST:

0.3100

CHANGE:
 0.00		OPEN:
0.3100		HIGH:
0.3100		ASK:
0.0000		VOLUME:
5.0K
CHG(%):
0.64		PREV:
0.3120		LOW:
0.3100		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 250.31000.31000.31000.31005.0K
22 Dec 250.31200.31200.31200.31205.0K
19 Dec 250.30400.30400.30400.30405.0K
18 Dec 250.30000.30000.30000.30005.0K
17 Dec 250.31200.31200.31200.31205.0K
16 Dec 250.31600.31600.31600.31605.0K
15 Dec 250.30600.30600.30600.30605.0K
12 Dec 250.29800.29800.29800.29805.0K
11 Dec 250.28600.28600.28600.28605.0K
10 Dec 250.30000.30000.30000.30005.0K

PROFILE

Name:RECCE PHARMACEUTICALS LTD
About:Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti"infectives in Australia, the United Kingdom, and the United States. The company's lead candidate is RECCE 327 (R327) for the treatment of life-threatening bacterial infections. In addition, its product pipeline comprises R327 Intravenous, which is in Phase I and Phase I/II clinical trial for the treatment of urinary tract infections/urosepsis; and R327 Topical Gel, which is Phase II clinical trial for the treatment of acute bacterial skin and skin structure infections, as well as is in Phase I/II clinical trials for topical wound infections and diabetic foot infections. The company has strategic partnership with Murdoch Children's Research Institute for development of the Acinetobacter baumannii and Mycobacterium abscessus; and cooperative research and development agreement with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to be tested against highly hazardous pathogens. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:Salesforce Tower, Sydney, NSW, Australia, 2000
Website:https://www.recce.com.au
ISIN:AU000000RCE5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-3.43 
Price to Sales:11.94 
Price to Book:190.88 
Profit Margin:-2.85 
Operating Margin:-23.70 
Return on Assets:-1.36 
Return on Equity:7.02 
Revenue:4.28M 
Shares:289.18M 
Market Cap:89.65M 

TECHNICAL INDICATORS

MA5:0.310.8%
MA10:0.301.8%
MA20:0.296.7%
MA50:0.2428.0%
MA100:0.2238.0%
MA200:0.1961.0%
STO9:80.00 
STO14:80.00 
RSI14:52.94
WPR14:-20.00 
MTM14:0.01
ROC14:0.02 
ATR:0.01 
Week High:0.321.9%
Week Low:0.303.3%
Month High:0.321.9%
Month Low:0.2161.0%
Year High:0.321.9%
Year Low:0.13142.2%
Volatility:21.35